Це відео не доступне.
Перепрошуємо.

How PRRT Can Improve Care for Neuroendocrine Tumor Patients

Поділитися
Вставка
  • Опубліковано 25 січ 2018
  • Neuroendocrine tumor patients now have wider access to Peptide Receptor Radionuclide Therapy (PRRT) following the January 2018 FDA approval of Lutetium 177 DOTA-TATE (Lu 177). PRRT was approved for the treatment of somatostatin-receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut tumors in adults. Medical experts discuss the advantages and risks of this newly approved treatment method.

КОМЕНТАРІ • 12

  • @latasha3472
    @latasha3472 2 роки тому +2

    This treatment gave me back my life .

  • @maureenzimerman6288
    @maureenzimerman6288 8 місяців тому

    I did well for over 2 years with having my prrt in Nashville at Vanderbilt. Now growth in liver has appeared. Available round 2 has been brought up.

  • @latasha3472
    @latasha3472 Рік тому +1

    Gotta do a second round 😢

    • @coolbreeze4576
      @coolbreeze4576 9 місяців тому

      My sister, I only saw your post on another video, and I'm encouraged by your faith and optimism. I know it can't be easy and I thank God for you. You were created and are here for a purpose. I hope you're being comforted and I pray for your total healing. I pray that your circumstances will change into continued victory and that you are surrounded by people who value and love you. God bless you.

  • @islamicreminders-uy9td
    @islamicreminders-uy9td 10 місяців тому

    How many sitting of PRRT treatment

  • @berndb.1381
    @berndb.1381 5 років тому

    Hey NETRF, great video! I am a nuclear medicine physician myself and want to create an explanatory video for the patienten in our own language. Some elements from you video could be of great help. What is the best way to get in touch in regards of this video and the animation? All the best!

    • @NETRF
      @NETRF  5 років тому

      NETRF did not do the animation. We secured permission from a third party. Please see the acknowledgments on the final screen for information.

    • @islamicreminders-uy9td
      @islamicreminders-uy9td 10 місяців тому

      Prrt treatment is pain ful

  • @reneecasey5853
    @reneecasey5853 5 років тому

    Do you have any recommendations for a patient that has neuroendocrine cancer, is not able to have surgery to remove it all, she did the prrt and it did not help her at all. Tumors continue to grow.

    • @NETRF
      @NETRF  5 років тому +2

      Renee, that is a hard question to answer, every case is very different. Not everyone responds to PRRT. We have videos on our UA-cam channel on interventional radiology, which is used for metastatic tumors to the liver. There are also clinical trials of new targeted therapies for NETs netrf.org/2018/08/09/study-to-look-for-predictive-biomarker/, netrf.org/2019/06/18/targeted-therapy-under-investigation/. Our conferences are a good place to learn all about the latest, we have a few coming up soon. Even if you can't make it. We will live stream on UA-cam. netrf.org/events/patient-and-caregiver-conferences/ Most people benefit most from finding a NET specialist netrf.org/for-patients/neuroendocrine-tumor-doctor-database/?doctor=doctor#sortables who is well versed in the latest options.

  • @EmaEma-ro3vw
    @EmaEma-ro3vw 4 роки тому

    This tumor Killed one of the india's finest legends "Irfan khan " 💔

  • @ronniev708
    @ronniev708 5 років тому

    Prrrrrt